Cite
Postmenopausalserum sex steroids and risk of hormone receptor-positive and -negative breastcancer: a nested case-control study
MLA
James RE, et al. Postmenopausalserum Sex Steroids and Risk of Hormone Receptor-Positive and -Negative Breastcancer: A Nested Case-Control Study. Jan. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3730..5cd1c8baf590b9f819557ee887edf161&authtype=sso&custid=ns315887.
APA
James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Mesrine S, Engel P, Clavel Chapelon F, Chang Claude J, Vrieling A, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, … Panico. (2011). Postmenopausalserum sex steroids and risk of hormone receptor-positive and -negative breastcancer: a nested case-control study.
Chicago
James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjønneland A, Olsen A, et al. 2011. “Postmenopausalserum Sex Steroids and Risk of Hormone Receptor-Positive and -Negative Breastcancer: A Nested Case-Control Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3730..5cd1c8baf590b9f819557ee887edf161&authtype=sso&custid=ns315887.